An Act To Repeal the 2-year Limit on Methadone and Suboxone Treatments under MaineCare
Be it enacted by the People of the State of Maine as follows:
Sec. 1. 22 MRSA §3174-SS, as enacted by PL 2011, c. 477, Pt. I, §1, is repealed.
Sec. 2. 22 MRSA §3174-VV, as reallocated by RR 2011, c. 2, §27, is repealed.
Current law limits to 24 months MaineCare coverage or reimbursement for buprenorphine and naloxone combination drugs, also known as Suboxone, for the treatment of addiction to opioids and for methadone for the treatment of addiction to opiates. This bill repeals the 24-month limit.